General Information of DTT (ID: TTQT5S9)

DTT Name Cambridge pathology 1 antigen (CD52) DTT Info
Gene Name CD52

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
1 Approved Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Alemtuzumab DMZL3IV Acute myelogenous leukaemia 2A41 Approved [1]
------------------------------------------------------------------------------------
1 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
GZ402668 DME6VX4 Multiple sclerosis 8A40 Phase 1 [2]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Identifying alemtuzumab as an anti-myeloid cell antiangiogenic therapy for the treatment of ovarian cancer. J Transl Med. 2009 Jun 19;7:49.
2 Characterization of a Next Generation Anti-CD52 Antibody. Neurology. April 6, 2015 vol. 84 no. 14.